Back to top

Vertex Pharmaceuticals (VRTX) Gets a Buy from Wells Fargo

Wells Fargo analyst Mohit Bansal maintained a Buy rating on Vertex Pharmaceuticals yesterday and set a price target of $460.00. The company’s share...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Vertex Pharmaceuticals Incorporated (VRTX)